Mount Sinai Researchers Discover New Target for Vaccine Development in Abundant Immune Cells July 24, 2012 Certain White Blood Cells May Be Useful in Vaccinating Against Blood-borne Infections and HIV.
Mount Sinai Researchers Present Studies On Treatment Trends, Myeloma Vaccine, and Predictive Models at Cancer Meeting May 17, 2012 Access to care, vaccine, treatment trends among landmark research at the 2012 American Society of Clinical Oncology meeting.
Young Immunology Researchers Receive Prestigious Grant For Outstanding Discoveries June 16, 2011 Benjamin tenOever, PhD, and Julie Magarian Blander, PhD, each received a grant from the Burroughs Wellcome Fund for their pioneering work in the study of infectious diseases
Study Finds That Those with Hard-to-Treat Forms of Hepatitis C Are Half As Likely to Begin Treatment November 9, 2009 Mount Sinai researchers conclude that patients with hard-to-treat forms of hepatitis C are less likely to seek treatment than those with less difficult-to-treat versions of the disease.
Benjamin Chen, MD, PhD, Wins NIDA 2009 Avant-Garde Award for Innovative HIV-AIDS Research September 24, 2009 The National Institute on Drug Abuse honored Dr. Chen for his work developing a method for visually tracking HIV virus particles from cell to cell.
